Priv.-Doz. Dr. Philipp Lohmann

PD Dr. Philipp Lohmann

* 03 October 1985, Nettetal, Germany

ORCID-ID: 0000-0002-5360-046X

EDUCATION

11/2020 Habilitation (Associate Professor), Venia Legendi and Venia Docendi in Medical Physics

University of Cologne, Faculty of Medicine, Cologne, Germany

06/2017 PhD in Theoretical Medicine (with distinction)

RWTH Aachen University, Faculty of Medicine, Aachen, Germany

07/2012 Master of Science in Biomedical Engineering

Aachen University of Applied Sciences, Juelich, Germany

ADDITIONAL SKILLS

Since 2018 International Conference on Harmonization – Good Clinical Practice (ICH-GCP)

Since 2016 Medical Physics Expert in Nuclear Medicine & Radiation Protection Officer

POSITIONS

Since 09/26 Acting Director – Medical Imaging Physics (INM-4), Institute of Neuroscience and Medicine,

Research Center Juelich (FZJ), Germany

Since 01/26 Head – Division for Digital Translational Neuroimaging, Institute of Neuroscience and Medicine

(INM-4), Research Center Juelich (FZJ), Germany (Director: Prof. Dr. N. Jon Shah)

Since 01/24 Guest Scientist, Department of Nuclear Medicine, University Hospital RWTH Aachen, Aachen

Germany (Director: Prof. Dr. F. Mottaghy)

11/20 – 07/25 Senior Researcher & Team Leader, Institute of Neuroscience and Medicine (INM-4), Research

Center Juelich (FZJ), Germany (Director: Prof. Dr. N. Jon Shah)

05/18 – 12/22 Research Associate, Department of Stereotaxy and Functional Neurosurgery, University

Hospital Cologne, Germany (Director: Prof. Dr. V. Visser-Vanderwalle)

Since 01/18 Member of the Working Group Neuro-Oncology, Department of Neurology, University Hospital

Cologne, Germany (Director: Prof. Dr. G. R. Fink)

HONORS & AWARDS

10/2024 Best Reviewer Award of the Medical Image Computing and Computer Assisted Intervention

(MICCAI) Society, USA

04/2024 Alavi-Mandell Award of the Society for Nuclear Medicine and Molecular Imaging (SNMMI)

for the publication “Automated Brain Tumor Detection and Segmentation for Treatment

Response Assessment Using Amino Acid PET”, J Nucl Med. 2023;64(10):1594-1602.

08/2023 Innovation Plus Award of the Research Center Juelich, Germany, for Approval of the

radiopharmaceutical 18F-fluoroethyltyrosine (FET) developed at the FZJ for brain tumor

diagnostics by the Federal Joint Committee (G-BA)

09/2021 Young Investigator Scholarship of the European Association of Neuro-Oncology (EANO),

Virtual Meeting

12/2020 Teaching Award 2020 as Member of the Team FH Aachen, Aachen University of Applied

Sciences, Aachen, Germany

11/2020 Poster Award of the Society for Neuro-Oncology (SNO), Virtual Meeting

10/2018 Poster Award of the European Association of Neuro-Oncology (EANO), Stockholm, Sweden

09/2018 Borchers Medal for Outstanding Doctoral Graduates, RWTH Aachen University, Aachen,

Germany

05/2018 Poster Award of the Working Group Neuro-Oncology within the German Cancer Society,

Cologne, Germany

05/2017 Poster Award of the World Federations of Neuro-Oncology Societies (WFNOS), Zurich,

Switzerland

Curriculum Vitae – Philipp Lohmann (09/2026)

2

INVOLVEMENT IN SCIENTIFIC SOCIETIES AND COMMMITTEES

- Chair of the Quality Assurance Committee of the European Organization for Research and Treatment

of Cancer (EORTC) Brain Tumor Group, Belgium

- Co-chair of the Brain Tumor Segmentation (BRATS) Brain Metastases Challenge 2024

- Co-initiator of the European Association of Neuro-Oncology (EANO) Career Boost Initiative

- Co-initiator and member of the American Society for Neuroradiology (ASNR) PET-guided Diagnosis

and Management in Neuro-oncology Study Group, USA

- Delegate of the German Federal Ministry of Research, Technology & Space (BMFTR) to the CERN

Knowledge Transfer Forum on Medical Applications

- Member of the Steering Committee of the EORTC Brain Tumor Group, Belgium

- Member of the Publishing Activity Committee of the EANO

- Member of the EORTC Brain Tumor and Imaging Group, Belgium

- Member of the Working Groups for Artificial Intelligence and Digitization and for Neuronuclear

Medicine of the German Society of Nuclear Medicine (DGN)

- Member of the Society for Neuro-Oncology (SNO), USA, the European Association of Neuro-Oncology

(EANO), Austria, the German Cancer Society (DKG), Germany, the German Society for Nuclear

Medicine (DGN), Germany, the Working Group Neuro-Oncology (NOA), Germany

ACTIVITIES AS EDITOR AND SCIENTIFIC REVIEWER

- Associate Editor for Neuro-Oncology

- Associate Editor for Neuro-Oncology Advances

- Topic Editor for Frontiers in Medicine: Nuclear Medicine in Cancer Diagnosis

- Guest Editor for Neuro-Oncology Advances Special Issue: Artificial Intelligence, Radiomics, and

Deep Learning in Neuro-Oncology

- Scientific Reviewer for the journals Lancet Oncology, Brain, Neuro-Oncology, The Journal of Nuclear

Medicine, European Journal of Nuclear Medicine and Molecular Imaging, European Radiology, etc.

- Grant Reviewer for the Medical University of Innsbruck, Austria, the Dutch Cancer Society (KWF),

The Netherlands, and the National Agency for Research (ANR), France, The Netherlands

Organization of Health, Research and Development (ZonMw), The Netherlands, etc.

INVITED PRESENTATIONS

11/2025 Invited Presentation: AI in Neuro-Oncology Practice – We are not ready

7th Quadriennal WFNOS and 30th Annual SNO Meeting, Honolulu, USA

11/2025 Invited Presentation: Artificial Intelligence for Neuroimaging

Education Day of the 7th Quadriennal WFNOS and 30th Annual SNO Meeting, Honolulu, USA

05/2025 Invited Presentation: Next Generation Imaging – Emerging PET Tracers in Neuro-Oncology

Annual ASNR Meeting, Philadelphia, USA

03/2025 Invited Presentation: 30 Years of PET/MRI Brain Tumor Diagnostics – Past, Present, Future

Division of Medical Imaging Physics Seminar Series, Indiana University, Indianapolis, USA

01/2025 Invited Presentation: Radiomics and AI in Neuro-Oncological PET

Egyptian Theranostics Summit, Online

05/2024 Invited Presentation: Machine Learning Approaches in Neurooncological PET

Annual ASNR Meeting, Las Vegas, USA

01/2024 Invited Presentation: Neuroimaging of Brain Metastases

EANO School of Medicine, Online

09/2023 Invited Presentation: The Promise of Radiomics & AI

Education Day of the Annual EANO Meeting, Rotterdam, The Netherlands

05/2023 Invited Presentation: Critical Role of Amino Acid PET Imaging in Neuro-Oncology

Annual ASNR Meeting, Chicago, USA

09/2022 Invited Keynote Presentation: Recurrent glioblastoma: Imaging

Annual EANO Meeting, Vienna, Austria

06/2022 Invited Presentation: Combining Advanced MRI and PET in the Follow-up of Glioma

European Academy of Neurology (EAN) Congress Europe, Vienna, Austria

03/2022 Invited Presentation: Translating Radiomics into Clinical Practice

Annual ASNR & WFNRS XXII Meeting, New York, USA

11/2021 Invited Presentation: AI & Radiomics in PET and MRI

Annual SNO Meeting, Boston, USA

1.     Bauer, Elena K., Gabriele Stoffels, Tobias Blau, Guido Reifenberger, Jörg Felsberg, Jan M. Werner, Philipp Lohmann, et al. ‘Prediction of Survival in Patients with IDH-Wildtype Astrocytic Gliomas Using Dynamic O-(2-[18F]-Fluoroethyl)-l-Tyrosine PET’. European Journal of Nuclear Medicine and Molecular Imaging 47 (2020): 1486–95. https://doi.org/10.1007/s00259-020-04695-0.

2.     Caldeira, Liliana, Elena Rota Kops, Seong Dae Yun, Nuno da Silva, Jorg Mauler, Christoph Weirich, Jurgen Scheins, et al. ‘The Jülich Experience With Simultaneous 3T MR-BrainPET: Methods and Technology’. IEEE Transactions on Radiation and Plasma Medical Sciences 3, no. 3 (2019): 352–62. https://doi.org/10.1109/TRPMS.2018.2863953.

3.     Ceccon, G., Philipp Lohmann, Jan-Michael Werner, Tscherpel Caroline, Veronika Dunkl, Gabriele Stoffels, Jurij Rosen, et al. ‘Early Treatment Response Assessment Using 18F-FET PET Compared to Contrast-Enhanced MRI in Glioma Patients after Adjuvant Temozolomide Chemotherapy’. Journal of Nuclear Medicine 62, no. 7 (2021): 918–25. https://doi.org/10.2967/jnumed.120.254243.

4.     Ceccon, Garry, Philipp Lohmann, Gabriele Stoffels, Natalie Judov, Christian Filss, Marion Rapp, Elena Bauer, et al. ‘Dynamic O -(2-18 F-Fluoroethyl)-L-Tyrosine Positron Emission Tomography Differentiates Brain Metastasis Recurrence from Radiation Injury after Radiotherapy’. Neuro-Oncology 19, no. 2 (2017): 281–88. https://doi.org/10.1093/neuonc/now149.

5.     D’Amore, Francesco, Farida Grinberg, Jörg Mauler, Norbert Galldiks, Ganna Blazhenets, Ezequiel Farrher, Christian Filss, et al. ‘Combined 18F-FET PET and Diffusion Kurtosis MRI in Post-Treatment Glioblastoma: Differentiation of True Progression from Treatment Related Changes’. Neuro-Oncology Advances 3, no. 1 (2021): vdab044. https://doi.org/10.1093/noajnl/vdab044.

6.     Filss, Christian P, Ann k Schmitz, Gabriele Stoffels, Carina Stegmayr, Philipp Lohmann, Jan Michael Werner, Michael Sabel, et al. ‘Flare Phenomenon in O-(2-[ 18 F]-Fluoroethyl)-L-Tyrosine PET after Resection of Gliomas’. Journal of Nuclear Medicine 61, no. 9 (2020): 1294–99. https://doi.org/10.2967/jnumed.119.238568.

7.     Filss, Christian P, Carina Stegmayr, Philipp Lohmann, Norbert Galldiks, and Karl-Josef Langen. ‘Reply to: Flare Phenomenon in O-(2-[(18)F]-Fluoroethyl)-L-Tyrosine PET after Resection of Gliomas: Potential Contribution from Postoperative Ischemia’. Journal of Nuclear Medicine 6, no. 12 (2020): 1852. https://doi.org/10.2967/jnumed.120.251819.

8.     Friedrich, Michel, Ezequiel Farrher, Svenja Caspers, Philipp Lohmann, Christoph Lerche, Gabriele Stoffels, Christian P. Filss, et al. ‘Alterations in White Matter Fiber Density Associated with Structural MRI and Metabolic PET Lesions Following Multimodal Therapy in Glioma Patients’. Frontiers in Oncology 12 (2022): 998069. https://doi.org/10.3389/fonc.2022.998069.

9.     Galldiks, Norbert, Diana SY Abdulla, Matthias Scheffler, Fabian Wolpert, Jan-Michael Werner, Martin W Huellner, Gabriele Stoffels, et al. ‘Treatment Monitoring of Immunotherapy and Targeted Therapy Using 18 F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences’. Journal of Nuclear Medicine 62, no. 4 (2021): 464–70. https://doi.org/10.2967/jnumed.120.248278.

10.  Galldiks, Norbert, Nathalie L Albert, Michael Wollring, Jan-Michael Werner, Philipp Lohmann, Javier E Villanueva-Meyer, Gereon R Fink, Karl-Josef Langen, and Joerg-Christian Tonn. ‘Advances in PET Imaging for Meningioma Patients’. Neuro-Oncology Advances 5, no. Supplement_1 (2023): i84–93. https://doi.org/10.1093/noajnl/vdac113.

11.  Galldiks, Norbert, Frank Angenstein, Jan-Michael Werner, Elena K. Bauer, Robin Gutsche, Gereon R. Fink, Karl-Josef Langen, and Philipp Lohmann. ‘Use of Advanced Neuroimaging and Artificial Intelligence in Meningiomas’. Brain Pathology 32, no. 2 (2022). https://doi.org/10.1111/bpa.13015.

12.  Galldiks, Norbert, Veronika Dunkl, Garry Ceccon, Caroline Tscherpel, Gabriele Stoffels, Ian Law, Otto M. Henriksen, et al. ‘Early Treatment Response Evaluation Using FET PET Compared to MRI in Glioblastoma Patients at First Progression Treated with Bevacizumab plus Lomustine’. European Journal of Nuclear Medicine and Molecular Imaging 45, no. 13 (2018): 2377–86. https://doi.org/10.1007/s00259-018-4082-4.

13.  Galldiks, Norbert, Werner Jan-Michael, Philipp Lohmann, Martin Kocher, Gereon Rudolf Fink, and Karl-Josef Langen. ‘Imaging of Response to Radiosurgery and Immunotherapy in Brain Metastses: Quo Vadis?’ Current Treatment Options in Neurology 23, no. 3 (2021): 7. https://doi.org/10.1007/s11940-021-00664-6.

14.  Galldiks, Norbert, and Philipp Lohmann. ‘Imaging Patterns in Patients with Newly Diagnosed Glioblastoma in England’. Neuro-Oncology Practice 9, no. 6 (2022): 461–62. https://doi.org/10.1093/nop/npac059.

15.  Galldiks, Norbert, Philipp Lohmann, Gereon R. Fink, and Karl-Josef Langen. ‘Amino Acid PET in Neurooncology’. Journal of Nuclear Medicine 64, no. 5 (2023): 693–700. https://doi.org/10.2967/jnumed.122.264859.

16.  Galldiks, Norbert, Philipp Lohmann, and Karl-Josef Langen. ‘Imaging Challenges Following Newer Treatment Options: Are Companion Diagnostics Required in Neurooncology?’ Expert Review of Molecular Diagnostics 20, no. 7 (2020): 651–52. https://doi.org/10.1080/14737159.2020.1782191.

17.  ———. ‘The Role of 11C-Methionine PET in Patients with Newly Diagnosed WHO Grade 2 or 3 Gliomas’. Neuro-Oncology 24, no. 9 (2022): 1557–58. https://doi.org/10.1093/neuonc/noac120.

18.  Galldiks, Norbert, Philipp Lohmann, Jan-Michael Werner, Garry Ceccon, Gereon R. Fink, and Karl-Josef Langen. ‘Molecular Imaging and Advanced MRI Findings Following Immunotherapy in Patients with Brain Tumors’. Expert Review of Anticancer Therapy 20, no. 1 (2020): 9–15. https://doi.org/10.1080/14737140.2020.1705788.

19.  Galldiks, Norbert, Marcus Unterrainer, Natalie Judov, Gabriele Stoffels, Marion Rapp, Philipp Lohmann, Franziska Vettermann, et al. ‘Photopenic Defects on O-(2-[18F]-Fluoroethyl)-L-Tyrosine PET - Clinical Relevance in Glioma Patients’. Neuro-Oncology 21, no. 10 (2019): 1331–38. https://doi.org/10.1093/neuonc/noz083.

20.  Galldiks, Norbert, Michael Wollring, Jan-Michael Werner, Michel Friedrich, Gereon R. Fink, Karl-Josef Langen, and Philipp Lohmann. ‘An Updated Review on the Diagnosis and Assessment of Post-Treatment Relapse in Brain Metastases Using PET’. Expert Review of Neurotherapeutics 22, no. 11–12 (2022): 915–21. https://doi.org/10.1080/14737175.2022.2162880.

21.  Galldiks, Norbert, Gelareh Zadeh, and Philipp Lohmann. ‘Artificial Intelligence, Radiomics, and Deep Learning in Neuro-Oncology’. Neuro-Oncology Advances 2, no. Supplement_4 (2021): iv1–2. https://doi.org/10.1093/noajnl/vdaa179.

22.  Geisler, Stefanie, Carina Stegmayr, Nicole Niemietz, Philipp Lohmann, Marion Rapp, Gabriele Stoffels, Antje Willuweit, et al. ‘Treatment-Related Uptake of O-(2-[ 18 F]Fluoroethyl)-L-Tyrosine and L-[Methyl- 3 H]-Methionine after Tumor Resection in Rat Glioma Model’. Journal of Nuclear Medicine 60, no. 10 (2019): 1373–79. https://doi.org/10.2967/jnumed.119.225680.

23.  Gutsche, Robin, Philipp Lohmann, Mauritius Hoevels, Daniel Ruess, Norbert Galldiks, Veerle Visser-Vandewalle, Harald Treuer, Maximilian Ruge, and Martin Kocher. ‘Radiomics Outperforms Semantic Features for Prediction of Response to Stereotactic Radiosurgery in Brain Metastases’. Radiotherapy and Oncology 166 (2022): 37–43. https://doi.org/10.1016/j.radonc.2021.11.010.

24.  Gutsche, Robin, Carsten Lowis, Karl Ziemons, Martin Kocher, Garry Ceccon, Cláudia Régio Brambilla, Nadim J Shah, et al. ‘Automated Brain Tumor Detection and Segmentation for Treatment Response Assessment Using Amino Acid PET.’ Journal of Nuclear Medicine 64, no. 8 (2023).

25.  Gutsche, Robin, Jürgen Scheins, Martin Kocher, Khaled Bousabarah, Gereon Rudolf Fink, N. J. Shah, Karl-Josef Langen, Norbert Galldiks, and Philipp Lohmann. ‘Evaluation of FET PET Radiomics Feature Repeatability in Glioma Patients’. Cancers 13, no. 4 (2021): 647-. https://doi.org/10.3390/cancers13040647.

26.  Heinzel, Alexander, Daniela Dedic, Norbert Galldiks, Philipp Lohmann, Gabriele Stoffels, Christian P. Filss, Martin Kocher, et al. ‘Two Decades of Brain Tumour Imaging with O-(2-[18F]Fluoroethyl)-L-Tyrosine PET: The Forschungszentrum Jülich Experience’. Cancers 14, no. 14 (2022): 3336-. https://doi.org/10.3390/cancers14143336.

27.  Heinzel, Alexander, Felix M. Mottaghy, Christian Filss, Gabriele Stoffels, Philipp Lohmann, Michel Friedrich, Nadim J. Shah, et al. ‘The Impact of Brain Lesions on Health-Related Quality of Life in Patients with WHO CNS Grade 3 or 4 Glioma: A Lesion-Function and Resting-State fMRI Analysis’. Journal of Neuro-Oncology 161 (2023): 643–54. https://doi.org/10.1007/s11060-023-04254-1.

28.  Kebir, Sied, Teresa Schmidt, Matthias Weber, Lazaros Lazaridis, Norbert Galldiks, Karl-Josef Langen, Christoph Kleinschnitz, et al. ‘A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma’. Cancers 12, no. 11 (2020): 3080-. https://doi.org/10.3390/cancers12113080.

29.  Kocher, Martin, Christiane Jockwitz, Svenja Caspers, Jan Schreiber, Ezequiel Farrher, Gabriele Stoffels, Christian Filss, et al. ‘Role of the Default Mode Resting-State Network for Cognitive Functioning in Malignant Glioma Patients Following Multimodal Treatment’. NeuroImage: Clinical 27 (2020): 102287-. https://doi.org/10.1016/j.nicl.2020.102287.

30.  Kocher, Martin, Christiane Jockwitz, Christoph Lerche, Michael Sabel, Philipp Lohmann, Gabriele Stoffels, Christian Filss, et al. ‘Case Report: Disruption of Resting-State Networks and Cognitive Deficits After Whole Brain Irradiation for Singular Brain Metastasis’. Frontiers in Neuroscience 15 (2021): 738708. https://doi.org/10.3389/fnins.2021.738708.

31.  Kocher, Martin, Christiane Jockwitz, Philipp Lohmann, Gabriele Stoffels, Christian Filss, Felix M. Mottaghy, Maximilian I. Ruge, et al. ‘Lesion-Function Analysis from Multimodal Imaging and Normative Brain Atlases for Prediction of Cognitive Deficits in Glioma Patients’. Cancers 13, no. 10 (2021): 2373-. https://doi.org/10.3390/cancers13102373.

32.  Kocher, Martin, Maximilian I. Ruge, Norbert Galldiks, and Philipp Lohmann. ‘Applications of Radiomics and Machine Learning for Radiotherapy of Malignant Brain Tumors’. Strahlentherapie Und Onkologie 196 (2020): 856–67. https://doi.org/10.1007/s00066-020-01626-8.

33.  Langen, Karl-Josef, Norbert Galldiks, and Philipp Lohmann. ‘Combined FET PET/ADC Mapping: Improved Imaging of Glioma Infiltration?’ Neuro-Oncology 22, no. 3 (2020): 313–14. https://doi.org/10.1093/neuonc/noz236.

34.  Langen, Karl-Josef, Norbert Galldiks, Philipp Lohmann, and Felix M. Mottaghy. ‘Boosting the Acceptance of 18F-FET PET for Image-Guided Treatment Planning with a Multi-Centric Prospective Trial’. European Journal of Nuclear Medicine and Molecular Imaging (2023): s00259-023-06426–27. https://doi.org/10.1007/s00259-023-06426-7.

35.  Langen, Karl-Josef, Norbert Galldiks, Jörg Mauler, Martin Kocher, Christian Peter Filß, Gabriele Stoffels, Cláudia Régio Brambilla, et al. ‘Hybrid PET/MRI in Cerebral Glioma: Current Status and Perspectives’. Cancers 15, no. 14 (2023): 3577-. https://doi.org/10.3390/cancers15143577.

36.  Langen, Karl-Josef, Alexander Heinzel, Philipp Lohmann, Felix M. Mottaghy, and Norbert Galldiks. ‘Advantages and Limitations of Amino Acid PET for Tracking Therapy Response in Glioma Patients’. Expert Review of Neurotherapeutics 20, no. 2 (2020): 137–46. https://doi.org/10.1080/14737175.2020.1704256.

37.  Langen, Karl-Josef, Gabriele Stoffels, Christian Filss, Alexander Heinzel, Carina Stegmayr, Philipp Lohmann, Antje Willuweit, Bernd Neumaier, Felix M. Mottaghy, and Norbert Galldiks. ‘Imaging of Amino Acid Transport in Brain Tumours: Positron Emission Tomography with O-(2-[ 18 F]Fluoroethyl)- L -Tyrosine (FET)’. Methods 130 (2017): 124–34. https://doi.org/10.1016/j.ymeth.2017.05.019.

38.  Lerche, Christoph W., Timon Radomski, Philipp Lohmann, Liliana Caldeira, Claudia Regio Brambilla, Lutz Tellmann, Jurgen Scheins, et al. ‘A Linearized Fit Model for Robust Shape Parameterization of FET-PET TACs’. IEEE Transactions on Medical Imaging 40, no. 7 (2021): 1852–62. https://doi.org/10.1109/TMI.2021.3067169.

39.  Lohmann, P., P. Stavrinou, K. Lipke, E. K. Bauer, G. Ceccon, J. M. Werner, B. Neumaier, et al. ‘FET PET Reveals Considerable Spatial Differences in Tumour Burden Compared to Conventional MRI in Newly Diagnosed Glioblastoma.’ European Journal of Nuclear Medicine and Molecular Imaging 46, no. 3 (2019): 591–602. https://doi.org/10.1007/s00259-018-4188-8.

40.  Lohmann, P., A. Willuweit, A. T. Neffe, S. Geisler, T. P. Gebauer, S. Beer, H. H. Coenen, et al. ‘Bone Regeneration Induced by a 3D Architectured Hydrogel in a Rat Critical-Size Calvarial Defect’. Biomaterials 113 (2017): 158–69. https://doi.org/10.1016/j.biomaterials.2016.10.039.

41.  Lohmann, Philipp, Khaled Bousabarah, Mauritius Hoevels, and Harald Treuer. ‘Radiomics in Radiation Oncology—Basics, Methods, and Limitations’. Strahlentherapie Und Onkologie 196 (2020): 848–55. https://doi.org/10.1007/s00066-020-01663-3.

42.  Lohmann, Philipp, Mai A. Elahmadawy, Robin Gutsche, Jan-Michael Werner, Elena K. Bauer, Garry Ceccon, Martin Kocher, et al. ‘FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-Chemoradiation’. Cancers 12, no. 12 (2020): 3835-. https://doi.org/10.3390/cancers12123835.

43.  Lohmann, Philipp, Enrico Franceschi, Philipp Vollmuth, Frédéric Dhermain, Michael Weller, Matthias Preusser, Marion Smits, and Norbert Galldiks. ‘Radiomics in Neuro-Oncological Clinical Trials’. The Lancet 4, no. 11 (2022): e841–49. https://doi.org/10.1016/S2589-7500(22)00144-3.

44.  Lohmann, Philipp, Norbert Galldiks, Martin Kocher, Alexander Heinzel, Christian P. Filss, Carina Stegmayr, Felix M. Mottaghy, Gereon R. Fink, N. J. Shah, and Karl-Josef Langen. ‘Radiomics in Neuro-Oncology: Basics, Workflow, and Applications’. Methods 188 (2021): 112–21. https://doi.org/10.1016/j.ymeth.2020.06.003.

45.  Lohmann, Philipp, Hans Herzog, Elena Rota Kops, Gabriele Stoffels, Christian Filss, Norbert Galldiks, Heinrich Hubert Coenen, N. Shah, and Karl-Josef Langen. ‘Adapting MR-BrainPET Scans for Comparison with Conventional PET: Experiences with Dynamic FET-PET in Brain Tumours’. EJNMMI Physics 1, no. Suppl 1 (2014): A64-. https://doi.org/10.1186/2197-7364-1-S1-A64.

46.  Lohmann, Philipp, Hans Herzog, Elena Rota Kops, Gabriele Stoffels, Natalie Judov, Christian Filss, Norbert Galldiks, et al. ‘Dual-Time-Point O-(2-[18F]Fluoroethyl)-L-Tyrosine PET for Grading of Cerebral Gliomas’. European Radiology 25, no. 10 (2015): 3017–24. https://doi.org/10.1007/s00330-015-3691-6.

47.  Lohmann, Philipp, M. Kocher, J. Steger, and N. Galldiks. ‘Radiomics Derived from Amino Acid PET and Conventional MRI in Patients with High-Grade Gliomas’. The Quarterly Journal of Nuclear Medicine and Molecular Imaging 62, no. 3 (2018): 272–80. https://doi.org/10.23736/S1824-4785.18.03095-9.

48.  Lohmann, Philipp, Martin Kocher, Garry Ceccon, Elena K. Bauer, Gabriele Stoffels, Shivakumar Viswanathan, Maximilian I. Ruge, et al. ‘Combined FET PET/MRI Radiomics Differentiates Radiation Injury from Recurrent Brain Metastasis’. NeuroImage: Clinical 20 (2018): 537–42. https://doi.org/10.1016/j.nicl.2018.08.024.

49.  Lohmann, Philipp, Martin Kocher, Maximillian I. Ruge, Veerle Visser-Vandewalle, N. Jon Shah, Gereon R. Fink, Karl-Josef Langen, and Norbert Galldiks. ‘PET/MRI Radiomics in Patients With Brain Metastases’. Frontiers in Neurology 11 (2020): 1. https://doi.org/10.3389/fneur.2020.00001.

50.  Lohmann, Philipp, Christoph Lerche, Elena K. Bauer, Jan Steger, Gabriele Stoffels, Tobias Blau, Veronika Dunkl, et al. ‘Predicting IDH Genotype in Gliomas Using FET PET Radiomics’. Scientific Reports 8, no. 1 (2018): 13328. https://doi.org/10.1038/s41598-018-31806-7.

51.  Lohmann, Philipp, Anna-Katharina Meißner, Martin Kocher, Elena K Bauer, Jan-Michael Werner, Gereon R Fink, Nadim J Shah, Karl-Josef Langen, and Norbert Galldiks. ‘Feature-Based PET/MRI Radiomics in Patients with Brain Tumors’. Neuro-Oncology Advances 2, no. Supplement_4 (2020): iv15–21. https://doi.org/10.1093/noajnl/vdaa118.

52.  Lohmann, Philipp, Marc D. Piroth, Bernd Sellhaus, Joachim Weis, Stefanie Geisler, Ana-Maria Oros-Peusquens, Hartmut Mohlberg, et al. ‘Correlation of Dynamic O-(2-[18F]Fluoroethyl)-L-Tyrosine Positron Emission Tomography, Conventional Magnetic Resonance Imaging, and Whole-Brain Histopathology in a Pretreated Glioblastoma: A Postmortem Study’. World Neurosurgery 119 (2018): e653–60. https://doi.org/10.1016/j.wneu.2018.07.232.

53.  Lohmann, Philipp, Gabriele Stoffels, Garry Ceccon, Marion Rapp, Michael Sabel, Christian Filss, Marcel A. Kamp, et al. ‘Radiation Injury vs. Recurrent Brain Metastasis: Combining Textural Feature Radiomics Analysis and Standard Parameters May Increase 18F-FET PET Accuracy without Dynamic Scans’. European Radiology 27, no. 7 (2017): 2916–27. https://doi.org/10.1007/s00330-016-4638-2.

54.  Lohmann, Philipp, Jan-Michael Werner, N. Shah, Gereon Rudolf Fink, Karl-Josef Langen, and Norbert Galldiks. ‘Combined Amino Acid Positron Emission Tomography and Advanced Magnetic Resonance Imaging in Glioma Patients’. Cancers 11, no. 2 (2019): 153-. https://doi.org/10.3390/cancers11020153.

55.  Ma, Bo, Michaela Gaens, Liliana Caldeira, Julian Bert, Philipp Lohmann, Lutz Tellmann, Christoph Lerche, et al. ‘Scatter Correction Based on GPU-Accelerated Full Monte Carlo Simulation for Brain PET/MRI’. IEEE Transactions on Medical Imaging 39, no. 1 (2020): 140–51. https://doi.org/10.1109/TMI.2019.2921872.

56.  Mauler, Jörg, Andrew A. Maudsley, Karl-Josef Langen, Omid Nikoubashman, Gabriele Stoffels, Sulaiman Sheriff, Philipp Lohmann, et al. ‘Spatial Relationship of Glioma Volume Derived from FET PET and Volumetric MRSI: A Hybrid PET-MRI Study’. Journal of Nuclear Medicine 59, no. 4 (2018): 603–9. https://doi.org/10.2967/jnumed.117.196709.

57.  Meißner, Anna-Katharina, Robin Gutsche, Norbert Galldiks, Martin Kocher, Stephanie T Jünger, Marie-Lisa Eich, Manuel Montesinos-Rongen, et al. ‘Radiomics for the Noninvasive Prediction of the BRAF Mutation Status in Patients with Melanoma Brain Metastases’. Neuro-Oncology 24, no. 8 (2022): 1331–40. https://doi.org/10.1093/neuonc/noab294.

58.  Meißner, Anna-Katharina, Robin Gutsche, Norbert Galldiks, Martin Kocher, Stephanie T. Jünger, Marie-Lisa Eich, Lucia Nogova, et al. ‘Radiomics for the Non-Invasive Prediction of PD-L1 Expression in Patients with Brain Metastases Secondary to Non-Small Cell Lung Cancer’. Journal of Neuro-Oncology 163, no. 3 (2023): 597–605. https://doi.org/10.1007/s11060-023-04367-7.

59.  Müller, Marguerite, Oliver Winz, Robin Gutsche, Ralph T. H. Leijenaar, Martin Kocher, Christoph Lerche, Christian P. Filss, et al. ‘Static FET PET Radiomics for the Differentiation of Treatment-Related Changes from Glioma Progression’. Journal of Neuro-Oncology 159 (2022): 519–29. https://doi.org/10.1007/s11060-022-04089-2.

60.  Ort, Jonas, Hussam Aldin Hamou, Julius M. Kernbach, Karlijn Hakvoort, Christian Blume, Philipp Lohmann, Norbert Galldiks, et al. ‘18F-FET-PET-Guided Gross Total Resection Improves Overall Survival in Patients with WHO Grade III/IV Glioma: Moving towards a Multimodal Imaging-Guided Resection’. Journal of Neuro-Oncology 155, no. 1 (2021): 71–80. https://doi.org/10.1007/s11060-021-03844-1.

61.  Post, Julia, Vanessa Kogel, Anja Schaffrath, Philipp Lohmann, N. J. Shah, Karl-Josef Langen, Dieter Willbold, Antje Willuweit, and Janine Kutzsche. ‘A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model’. Molecules 26, no. 6 (2021): 1590-. https://doi.org/10.3390/molecules26061590.

62.  Rosen, Jurij, Gabriele Stoffels, Philipp Lohmann, Elena K. Bauer, Jan-Michael Werner, Michael Wollring, Marion Rapp, et al. ‘Prognostic Value of Pre-Irradiation FET PET in Patients with Not Completely Resectable IDH-Wildtype Glioma and Minimal or Absent Contrast Enhancement’. Scientific Reports 11, no. 1 (2021): 20828. https://doi.org/10.1038/s41598-021-00193-x.

63.  Scheins, Jürgen, Christoph Weirich, Liliana Caldeira, Philipp Lohmann, Elena Rota Kops, Lutz Tellmann, Michaela Gaens, Hans Herzog, Uwe Pietrzyk, and N. Shah. ‘High-Resolution, Quantitative 3D PET Image Reconstruction for the Siemens Hybrid 3T MR/BrainPET Scanner Using the PET Reconstruction Software Toolkit (PRESTO)’. EJNMMI Physics 1, no. Suppl 1 (2014): A51-. https://doi.org/10.1186/2197-7364-1-S1-A51.

64.  Shymanskaya, Aliaksandra, Wieland A. Worthoff, Gabriele Stoffels, Johannes Lindemeyer, Bernd Neumaier, Philipp Lohmann, Norbert Galldiks, Karl-Josef Langen, and N. J. Shah. ‘Comparison of [18F]Fluoroethyltyrosine PET and Sodium MRI in Cerebral Gliomas: A Pilot Study’. Molecular Imaging & Biology 22, no. (2020): 198–207. https://doi.org/10.1007/s11307-019-01349-y.

65.  Silva, N. A. da, P. Lohmann, J. Fairney, A. W. Magill, A.-M. Oros Peusquens, C.-H. Choi, R. Stirnberg, et al. ‘Hybrid MR-PET of Brain Tumours Using Amino Acid PET and Chemical Exchange Saturation Transfer MRI’. European Journal of Nuclear Medicine and Molecular Imaging 45, no. 6 (2018): 1031–40. https://doi.org/10.1007/s00259-018-3940-4.

66.  Stegmayr, Carina, Ulrike Bandelow, Dennis Oliveira, Philipp Lohmann, Antje Willuweit, Christian Filss, Norbert Galldiks, et al. ‘Influence of Blood-Brain Barrier Permeability on O-(2-18F-Fluoroethyl)-L-Tyrosine Uptake in Rat Gliomas’. European Journal of Nuclear Medicine and Molecular Imaging 44, no. 3 (2017): 408–16. https://doi.org/10.1007/s00259-016-3508-0.

67.  Stegmayr, Carina, Dennis Oliveira, Nicole Niemietz, Antje Willuweit, Philipp Lohmann, Norbert Galldiks, N. J. Shah, Johannes Ermert, and Karl-Josef Langen. ‘Influence of Bevacizumab on Blood-Brain Barrier Permeability and O-(2- 18 F-Fluoroethyl)-L-Tyrosine Uptake in Rat Gliomas’. Journal of Nuclear Medicine 58, no. 5 (2017): 700–705. https://doi.org/10.2967/jnumed.116.187047.

68.  Stegmayr, Carina, Gabriele Stoffels, Christian Filß, Alexander Heinzel, Philipp Lohmann, Antje Willuweit, Johannes Ermert, et al. ‘Current Trends in the Use of O-(2-[18F]Fluoroethyl)-L-Tyrosine ([18F]FET) in Neurooncology’. Nuclear Medicine and Biology 92 (2021): 78–84. https://doi.org/10.1016/j.nucmedbio.2020.02.006.

69.  Stegmayr, Carina, Gabriele Stoffels, Elena Rota Kops, Philipp Lohmann, Norbert Galldiks, Nadim J. Shah, Bernd Neumaier, and Karl-Josef Langen. ‘Influence of Dexamethasone on O-(2-[18F]-Fluoroethyl)-l-Tyrosine Uptake in the Human Brain and Quantification of Tumor Uptake’. Molecular Imaging & Biology 21, no. 1 (2019): 168–74. https://doi.org/10.1007/s11307-018-1221-z.

70.  Stegmayr, Carina, Antje Willuweit, Philipp Lohmann, and Karl-Josef Langen. ‘O‑(2‑[18F]‑fluoroethyl)-L‑tyrosine (FET) in Neurooncology: A Review of Experimental Results’. Current Radiopharmaceuticals 12, no. 3 (2019): 201–10. https://doi.org/10.2174/1874471012666190111111046.

71.  Steidl, Eike, Karl-Josef Langen, Sarah Abu Hmeidan, Nenad Polomac, Christian P. Filss, Norbert Galldiks, Philipp Lohmann, et al. ‘Sequential Implementation of DSC-MR Perfusion and Dynamic [18F]FET PET Allows Efficient Differentiation of Glioma Progression from Treatment-Related Changes’. European Journal of Nuclear Medicine and Molecular Imaging 48 (2021): 1956–65. https://doi.org/10.1007/s00259-020-05114-0.

72.  Verger, Antoine, Christian Filss, Philipp Lohmann, Gabriele Stoffels, Michael Sabel, Hans J. Wittsack, Elena Rota Kops, et al. ‘Comparison of 18F-FET PET and Perfusion-Weighted MRI for Glioma Grading: A Hybrid PET/MR Study’. European Journal of Nuclear Medicine and Molecular Imaging 44, no. 13 (2017): 2257–65. https://doi.org/10.1007/s00259-017-3812-3.

73.  Verger, Antoine, Christian Filss, Philipp Lohmann, Gabriele Stoffels, Michael Sabel, Hans-J. Wittsack, Elena Rota Kops, et al. ‘Comparison of O-(2-18F-Fluoroethyl)-L-Tyrosine Positron Emission Tomography and Perfusion-Weighted Magnetic Resonance Imaging in the Diagnosis of Patients with Progressive and Recurrent Glioma: A Hybrid Positron Emission Tomography/Magnetic Resonance Study’. World Neurosurgery 113 (2018): e727–37. https://doi.org/10.1016/j.wneu.2018.02.139.

74.  Verger, Antoine, Carina Stegmayr, Norbert Galldiks, Axel Van Der Gucht, Philipp Lohmann, Gabriele Stoffels, Nadim J. Shah, et al. ‘Evaluation of Factors Influencing 18 F-FET Uptake in the Brain’. NeuroImage: Clinical 17 (2018): 491–97. https://doi.org/10.1016/j.nicl.2017.11.005.

75.  Verger, Antoine, Gabriele Stoffels, Elena K. Bauer, Philipp Lohmann, Tobias Blau, Gereon R. Fink, Bernd Neumaier, Nadim J. Shah, Karl-Josef Langen, and Norbert Galldiks. ‘Static and Dynamic 18F–FET PET for the Characterization of Gliomas Defined by IDH and 1p/19q Status’. European Journal of Nuclear Medicine and Molecular Imaging 45, no. 3 (2018): 443–51. https://doi.org/10.1007/s00259-017-3846-6.

76.  Verger, Antoine, Gabriele Stoffels, Norbert Galldiks, Philipp Lohmann, Antje Willuweit, Bernd Neumaier, Stefanie Geisler, and Karl-Josef Langen. ‘Investigation of Cis-4-[18F]Fluoro-D-Proline Uptake in Human Brain Tumors After Multimodal Treatment’. Molecular Imaging & Biology 20, no. 6 (2018): 1035–43. https://doi.org/10.1007/s11307-018-1197-8.

77.  Volz, L. J., M. Kocher, P. Lohmann, N. J. Shah, G. R. Fink, and N. Galldiks. ‘Functional Magnetic Resonance Imaging in Glioma Patients: From Clinical Applications to Future Perspectives’. The Quarterly Journal of Nuclear Medicine and Molecular Imaging 62, no. 3 (2018): 295–302. https://doi.org/10.23736/S1824-4785.18.03101-1.

78.  Weirich, C., J. Scheins, P. Lohmann, L. Tellmann, L. Byars, C. Michel, E. Rota Kops, D. Brenner, H. Herzog, and N.J. Shah. ‘Quantitative PET Imaging with the 3T MR-BrainPET’. Nuclear Instruments & Methods in Physics Research / A 702 (2013): 26–28. https://doi.org/10.1016/j.nima.2012.08.068.

79.  Werner, J. M., P. Lohmann, G. R. Fink, K. J. Langen, and N. Galldiks. ‘Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors’. Molecules 25, no. 6 (2020): 1471. https://doi.org/10.3390/molecules25061471.

80.  Werner, Jan-Michael, Gabriele Stoffels, Thorsten Lichtenstein, Jan Borggrefe, Philipp Lohmann, Garry Ceccon, Nadim J. Shah, et al. ‘Differentiation of Treatment-Related Changes from Tumour Progression: A Direct Comparison between Dynamic FET PET and ADC Values Obtained from DWI MRI’. European Journal of Nuclear Medicine and Molecular Imaging 46, no. 9 (2019): 1889–1901. https://doi.org/10.1007/s00259-019-04384-7.

81.  Werner, Jan-Michael, Johannes Weller, Garry Ceccon, Christina Schaub, Caroline Tscherpel, Philipp Lohmann, Elena K. Bauer, et al. ‘Diagnosis of Pseudoprogression Following Lomustine–Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET’. Clinical Cancer Research 27, no. 13 (2021): 3704–13. https://doi.org/10.1158/1078-0432.CCR-21-0471.

82.  Willuweit, Antje, Michael Schöneck, Sarah Schemmert, Philipp Lohmann, Saskia Bremen, Dominik Honold, Nicole Burda, et al. ‘Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography’. Frontiers in Neuroscience 15 (2021): 699926. https://doi.org/10.3389/fnins.2021.699926.

83.  Wollring, Michael M, Jan-Michael Werner, Elena K Bauer, Caroline Tscherpel, Garry S Ceccon, Philipp Lohmann, Gabriele Stoffels, et al. ‘Prediction of Response to Lomustine-Based Chemotherapy in Glioma Patients at Recurrence Using MRI and FET PET’. Neuro-Oncology 25, no. 5 (2023): 984–94. https://doi.org/10.1093/neuonc/noac229.

84.  Wollring, Michael M., Jan-Michael Werner, Garry Ceccon, Philipp Lohmann, Christian P. Filss, Gereon R. Fink, Karl-Josef Langen, and Norbert Galldiks. ‘Clinical Applications and Prospects of PET Imaging in Patients with IDH-Mutant Gliomas’. Journal of Neuro-Oncology 162 (2023): 481–88. https://doi.org/10.1007/s11060-022-04218-x.